EXAI News and Press, Exscientia Limited From 07/12/22

AlphaFold is a leading open-source AI program that aids researchers in visualizing protein structures. Applications are diverse and reduce research time across the healthcare industry and academia. The program certainly is a gift to our future health, but the open source nature an...

The following slide deck was published by Exscientia plc in conjunction with this event. For further details see: Exscientia (EXAI) Investor Presentation - Slideshow

Clinical data builds upon body of evidence suggesting EXS-21546 is a highly potent and selective A 2A R antagonist with low CNS exposure Exscientia anticipates initiating Phase 1b/2 in patients with high adenosine signature cancers in second half of 2022 Ongoing tr...

Exscientia (Nasdaq: EXAI) today announced that Andrew Hopkins, DPhil., Exscientia’s founder and CEO, and Dave Hallett, Chief Operations Officer, will participate in a fireside chat at the Goldman Sachs 43 rd Annual Global Healthcare Conference on Tuesday, June 14, 2022 at 9:2...

Exscientia plc (EXAI) Q1 2022 Earnings Conference Call May 26, 2022 08:30 AM ET Company Participants Sara Sherman - Vice President of Investor Relations Andrew Hopkins - Chief Executive Officer Nikolaus Krall - Vice President of Precision Medicine Ben Taylor - Chief Financial Officer and Chie...

The following slide deck was published by Exscientia plc in conjunction with their 2022 Q1 earnings call. For further details see: Exscientia plc 2022 Q1 - Results - Earnings Call Presentation

Exscientia press release (NASDAQ:EXAI): Q1 GAAP EPS of -£0.41. Revenue of £9.2M (+31.4% Y/Y) misses by £23.2M. For further details see: Exscientia GAAP EPS of -£0.41, revenue of £9.2M misses by £23.2M

Exscientia plc (Nasdaq: EXAI) This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220525005906/en/ Recent advancements in the Company’s pipeline, collaborations, and operations, as well as financial results for ...

Company to host conference call and webcast on May 26, 2022 at 1:30 p.m. BST / 8:30 a.m. ET Exscientia (Nasdaq: EXAI), an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner, will re...

Exscientia (Nasdaq: EXAI) today announced that Ben Taylor, CFO & Chief Strategy Officer and Garry Pairaudeau, Chief Technology Officer, will participate in a fireside chat at the BofA Securities 2022 Healthcare Conference on Tuesday, May 10, 2022 at 5:20 p.m. P.T. A live webcast...